02320nas a2200253 4500000000100000008004100001260001600042100001100058700001400069700001200083700001600095700001800111700001300129700001100142700001300153700001500166700001400181245013600195250001500331300001200346490000700358520165000365020005102015 2012 d c300067309151 aLam T.1 aHuxley R.1 aFang X.1 aMurakami Y.1 aWoodward Mark1 aBarzi F.1 aSuh I.1 aBatty G.1 aWebster R.1 aRodgers A00aThe association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts a2012/06/22 a719-7260 v213 a
BACKGROUND: Multiple studies have examined the relationship between heart rate and mortality; however, there are discrepancies in results. Our aim was to describe the relationship between resting heart rate (RHR) and both major cardiovascular (CV) outcomes, as well as all-cause mortality in the Asia-Pacific region. DESIGN AND METHODS: Individual data from 112,680 subjects in 12 cohort studies were pooled and analysed using Cox models, stratified by study and sex, and adjusted for age and systolic blood pressure. RESULTS: During a mean 7.4 years follow-up, 6086 deaths and 2726 fatal or nonfatal CV events were recorded. There was a continuous, increasing association between having a RHR above approximately 65 beats/min and the risk of both CV and all-cause mortality, yet there was no evidence of associations below this threshold. The hazard ratio (95% CI) comparing the extreme quarters of RHR (80+ v <65 beats/min) was 1.44 (1.29-1.60) for CV and 1.54 (1.43-1.66) for total mortality. These associations were not materially changed by adjustment for other risk factors and exclusion of the first 2 years of follow-up. Hazard ratios of a similar magnitude were found for ischemic and hemorrhagic stroke, but the hazard ratio for heart failure was higher (2.08, 95% CI 1.07-4.06) and for Coronary Heart Disease (CHD) was lower (1.11, 95% CI 0.93-1.31) than for stroke. CONCLUSIONS: RHR of above 65 beats/min has a strong independent effect on premature mortality and stroke, but a lesser effect on CHD. Lifestyle and pharmaceutical regimens to reduce RHR may be beneficial for people with moderate to high levels of RHR.
a2047-4881 (Electronic)